New methods for early diagnosis of lung cancer : Early invasive lung cancer: New diagnostic tool and treatment strategiesVAN ZANDWIJK, Nico.Lung cancer. 2002, Vol 38, pp S9-S11, issn 0169-5002, SUP1Conference Paper

New methods for early diagnosis of lung cancer : Early Invasive Lung Cancer: New Diagnostic Tools and Treatment StrategiesVAN ZANDWIJK, Nico.Lung cancer. 2002, Vol 38, Num 1, pp S9-S11, issn 0169-5002Conference Paper

Chemoprevention in lung carcinogenesis : An overviewVAN ZANDWIJK, Nico.European journal of cancer (1990). 2005, Vol 41, Num 13, pp 1990-2002, issn 0959-8049, 13 p.Article

Circulating microRNAs: Association with disease and potential use as biomarkersREID, Glen; KIRSCHNER, Michaela B; VAN ZANDWIJK, Nico et al.Critical reviews in oncology/hematology. 2011, Vol 80, Num 2, pp 193-208, issn 1040-8428, 16 p.Article

Chemoprevention of lung cancerVAN ZANDWIJK, Nico.Lung cancer. 2001, Vol 34, pp S91-S94, issn 0169-5002, SUP3Conference Paper

Limited efficacy of imatinib mesylate in malignant mesothelioma : A phase II trialMATHY, Alexandre; BAAS, Paul; DALESIO, Otilia et al.Lung cancer. 2005, Vol 50, Num 1, pp 83-86, issn 0169-5002, 4 p.Article

Thalidomide in patients with malignant pleural mesotheliomaBAAS, Paul; BOOGERD, Willem; DALESIO, Otilia et al.Lung cancer. 2005, Vol 48, Num 2, pp 291-296, issn 0169-5002, 6 p.Article

Chemoprevention of lung cancer: current status and future prospectsVAN ZANDWIJK, Nico; HIRSCH, Fred R.Lung cancer. 2003, Vol 42, pp S71-S79, issn 0169-5002, SUP1Conference Paper

Neoadjuvant strategies for non-small cell lung cancerVAN ZANDWIJK, Nico.Lung cancer. 2001, Vol 34, pp S145-S150, issn 0169-5002, SUP2Conference Paper

INFLUENCE OF HEAT AND MOISTURE EXCHANGER RESPIRATORY LOAD ON TRANSCUTANEOUS OXYGENATION IN LARYNGECTOMIZED INDIVIDUALS : A RANDOMIZED CROSSOVER STUDYKAREL ZUUR, J; MULLER, Sara H; SINAASAPPEL, Michiel et al.Head & neck. 2007, Vol 29, Num 12, pp 1102-1110, issn 1043-3074, 9 p.Article

High Blood Neutrophil-to-Lymphocyte Ratio Is an Indicator of Poor Prognosis in Malignant Mesothelioma Patients Undergoing Systemic TherapyKAO, Steven C. H; PAVLAKIS, Nick; HARVIE, Rozelle et al.Clinical cancer research (Print). 2010, Vol 16, Num 23, pp 5805-5813, issn 1078-0432, 9 p.Article

Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: Why pneumonectomy should be avoidedKAPPERS, Ingrid; VAN SANDICK, Johanna W; BURGERS, Sjaak A et al.Lung cancer. 2010, Vol 68, Num 2, pp 222-227, issn 0169-5002, 6 p.Article

Prognostic significance of ^99mTc hynic-rh-annexin v scintigraphy during platinum-based chemotherapy in advanced lung cancerKARTACHOVA, Marina; VAN ZANDWIJK, Nico; BURGERS, Sjaak et al.Journal of clinical oncology. 2007, Vol 25, Num 18, pp 2534-2539, issn 0732-183X, 6 p.Article

The prognostic significance of a previous malignancy in operable non-small cell lung cancerKOPPE, Manuel J; ZOETMULDER, Frans A. N; VAN ZANDWIJK, Nico et al.Lung cancer. 2001, Vol 32, Num 1, pp 47-53, issn 0169-5002Article

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancerVAN ZANDWIJK, Nico; DALESIO, Otilia; PASTORINO, Ugo et al.Journal of the National Cancer Institute. 2000, Vol 92, Num 12, pp 977-986, issn 0027-8874Article

Second-line erlotinib in patients with advanced non-small-cell lung cancer: Subgroup analyses from the TRUST studyHEIGENER, David F; WU, Yi-Long; VAN ZANDWIJK, Nico et al.Lung cancer. 2011, Vol 74, Num 2, pp 274-279, issn 0169-5002, 6 p.Article

Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancersRUIVENKAMP, Claudia A. L; VAN WEZEL, Tom; GROOT, Peter C et al.Nature genetics. 2002, Vol 31, Num 3, pp 295-300, issn 1061-4036Article

Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma : Dose finding and toxicity resultsSCHOUWINK, Hugo; RUTGERS, Emiel T; VAN DER SIJP, Joost et al.Chest. 2001, Vol 120, Num 4, pp 1167-1174, issn 0012-3692Article

SURVIVAL AFTER SURGICAL RESECTION OF PULMONARY METASTASES AND SECOND PRIMARY SQUAMOUS CELL LUNG CARCINOMAS IN HEAD AND NECK CANCERGEURTS, Thomas W; BALM, Alfons J. M; VAN VELTHUYSEN, Marie-Louise F et al.Head & neck. 2009, Vol 31, Num 2, pp 220-226, issn 1043-3074, 7 p.Article

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancerVAN MEERBEECK, Jan P; KRAMER, Gijs W. P. M; SPLINTER, Ted A. W et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 6, pp 442-450, issn 0027-8874, 9 p.Article

Quality assurance of thoracic radiotherapy in EORTC 08941 : A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapyKRAMER, Gijsbert W. P. M; LEGRAND, Catherine L; GIACCONE, Giuseppe et al.European journal of cancer (1990). 2006, Vol 42, Num 10, pp 1391-1398, issn 0959-8049, 8 p.Article

Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resectionKAPPERS, Ingrid; VAN SANDICK, Johanna W; BURGERS, Jacques A et al.European journal of cardio-thoracic surgery. 2009, Vol 36, Num 4, pp 741-746, issn 1010-7940, 6 p.Article

CT detected indeterminate pulmonary nodules in a chemoprevention trial of fluticasoneVAN DEN BERG, Remco M; JELLE TEERTSTRA, H; SMIT, Egbert F et al.Lung cancer. 2008, Vol 60, Num 1, pp 57-61, issn 0169-5002, 5 p.Article

Relationship between cisplatin administration and the development of ototoxicityRADEMAKER-LAKHAI, Jeany M; CRUL, Mirjam; ZUUR, Lot et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 918-924, issn 0732-183X, 7 p.Article

Effects of oral administration of N-acetyl-L-cysteine: A multi-biomarker study in smokersVAN SCHOOTEN, Frederik Jan; AHMAD BESARATI NIA; VAN'T VEER, Laura et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 2, pp 167-175, issn 1055-9965Article